Live Courses

View Other Dates

July 6-12, 2022 NAPLEX & Clinical CPJE, 7-day Live Virtual Course

Course Information


Location: 7 Days Live Virtual Class Room

Dates: July 6-12, 2022

Live Course Fee: $1,350.00

Add To Cart

Live Course + Online Course Bundle

Register for both Live and Online Course and save!

Bundle Fee: $1,650
Add To Cart

Structure


7-Day Live Virtual Classroom Board Review: Focusing on NAPLEX® and the clinical pharmacy portion of CPJE (No Law). This is a live streaming class with the participants and speakers all in a virtual classroom where participants can see and interact with the instructors and other students during the 7-day review. 

Note:
Due to time constraints, not all the topics covered in the coursebook and online course can be covered during the live review. We, therefore, recommend the BUNDLE COURSE (combo of 7-day live class attendance plus 12-month access to pre-recorded online video lectures.) To get the most out of the live course, we recommend students go through the online video lectures and question bank prior to attending the live class. This is a recommendation, but not a requirement.

Coursebook: 700 pages of FOCUSED, HIGH YIELD material accompanying the lectures. No fluff or unnecessary information. You will receive your coursebook within 4-7 business days.

Question Bank: 2500 online question bank with an abundance of patient profile questions and detailed explanations (see demo).

Two Practice Exams: 100 questions each.

Chart Book: 100-page Chartbook to help with the memorization of details.

Support: Pharmacy board experts, Dr. Yavari & Dr. Miremadi's support and assistance via email. 

July 06 - 12, 2022        Live Course dates & hours (PST):
July 06 - Wednesday    8 AM - 5 PM Pacific Standard Time
July 07 - Thursday        8 AM - 5 PM Pacific Standard Time

July 08 - Friday             8 AM - 5 PM Pacific Standard Time
July 09 - Saturday         8 AM - 5 PM Pacific Standard Time
July 10 - Sunday           8 AM - 5 PM Pacific Standard Time        
July 11 - Monday           8 AM - 5 PM Pacific Standard Time
July 12 - Tuesday          8 AM - 5 PM Pacific Standard Time

Notes: 
1. After registration, if you need to postpone your live class attendance to a future date, you can do so by sending us an email. We have live 7-day classes open to the public once about every 8-10 weeks.

2. The registration deadline to receive coursebooks in time is June 27th.

3. NO LAW lectures:
The 7-day Live board review is solely CLINICAL pharmacy lectures for NAPLEX and the Clinical portion of CPJE. The Law portion of CPJE is covered by CA Law Online Course.

Access to Online Question Bank is included with the Live course: 2500 Board-type questions with answers, detailed explanations & patient profile cases to solidify your understanding of the material. 


The questions are formatted to include patient profiles, fill-in-the-blank calculations, and standard multiple-choice questions. 


Progress Tracking allows you to follow and manage your question bank results, and evaluate your progress on your user dashboard. At the end of your study, we have two comprehensive practice tests to conclude the material that has been covered. 

Case:
SJ is a 39-year-old male patient with a history significant for penetrating head trauma two weeks ago. Today, he presented to the local hospital ED with a chief complaint of lethargy, severe headache, fever, chills, nausea for one day.

Upon hearing SJ's complaints, the triage nurse placed him in an isolation room for further workup.

Past Medical History:
Penetrating head trauma with a knife during a bar fight two weeks ago

Home Medications: 
None

Allergies: Vancomycin: anaphylactic reaction seven years ago

Physical Exam:
Weight: 70 kg    Height: 185 cm
Vitals: BP: 166/85 mmHg,   Pulse: 114   Resp Rate: 20   Temp 103.1C     O2Sat: 98%
Appearance: Moderate distress; alert and oriented to time, place, and person
Exam significant for nuchal rigidity, and positive Babinski sign

ER course: Lumbar puncture was performed

CSF Preliminary Report:
Gram-positive cocci in clusters 
Coagulase positive

CSF culture and sensitivity: pending

Hospital course:
The attending physician orders IV ceftriaxone and IV Bactrim for empiric treatment.

Question:
Based on the cerebrospinal fluid preliminary report after the lumbar puncture, which of the following bacteria is the most likely cause of SJ's infection?
Answer:
Case:
TA is a 62-year-old female diagnosed with endometrial cancer currently undergoing chemotherapy. 

LABS:

CBC w/ Diff

Normal Range

Day 1

Day 8

Day 15

Day 22

WBC

(4.5 - 10) x 103 per µL 

9.9 

8.9

9.6

9.8

Hemoglobin

12.0 - 15.5 g/dL female

13.5 - 16.5 g/dL male

14.5 

11.9

9.2

8.0

Hematocrit

35.0 - 50.0 %

42.7

33.4

27.8

24.1

MCV

80.0 - 100.0 fL

85.2

88.2

91.4

89.5

Platelet

150 - 450 thou/µL

278 

287 

265

278

Neutrophil

50 - 75 %

58

51

58

55

Lymphocytes

20 - 44 %

32

29

30

33

Monocytes

0 - 10 %

3

6

5

3

Eosinophils

1 - 7 %

2

6

4

3

Basophils

1 - 5 %

2

4

2

4

Bands

0 - 5 %

3

4

1

2

 

Question:

Which of the following medications are used to treat the chemotherapy-induced complication TA is experiencing? Select ALL that apply.

Answer:
Case:
KG is a 58-year-old male patient admitted to the hospital yesterday for acute pancreatitis secondary to alcohol use. 

Past Medical History:
Alcohol use disorder

Allergies:
Sulfa

Labs:

CMP

Normal Range

Day 1

Sodium

135 - 145 mEq/L

139

Potassium

3.5 - 5.2 mEq/L

4.5 

Chloride

97 - 108 mEq/L

105

Bicarb

23 - 29 mEq/L

25

BUN

6 - 20 mg/dL

18 

Cr

0.6 - 1.3 mg/dL

1.0

Glucose

70 - 100 mg/dL

89

eGFR

90 - 120 mL/min/1.73

95

ALT

< 35  U/L

14

AST

< 35  U/L

12

Bilirubin

0.3 - 1.9 mg/dL

1.1

Albumin

3.4 - 5.4 g/dL

4.7


CBC w/ Diff

Normal Range

Day 1

WBC

(4.5 - 10) x 103 per µL 

9.9 

Hemoglobin

12.0 - 15.5 g/dL female

13.5 - 16.5 g/dL male

14.5 

Hematocrit

35.0 - 50.0 %

42.7

MCV

80.0 - 100.0 fL

85.2

Platelet

150 - 450 thou/µL

278 

Neutrophil

50 - 75 %

55

Lymphocytes

20 - 44 %

32

Monocytes

0 - 10 %

3

Eosinophils

1 - 7 %

2

Basophils

1 - 5 %

2

Bands

0 - 5 %

3



 

Normal range

Day 1

Lipase

60 - 140 U/L

660

Amylase

30 - 110 to U/L

528


Hospital Orders:
NPO
D5 1/2 NS IV fluid at 75 mL/hour


Hospital Course:
Day 1: Non-eventful; patient stable
Day 2: 08:21 AM: The patient was unresponsive, turning blue in color, and not breathing. Code blue was called, and the cause for the respiratory paralysis was found to be the accidental administration of vecuronium by the nurse.

Question:
Which of the following measures could have been of help prior to the event in preventing the sentinel event that occurred on Day 2 of KG's hospital stay? Select ALL that apply.
Answer:
Case:
RC is a 29-year-old female patient with HIV. She has been on a HAART medication regimen for the last year. Her HIV specialist has been following her CBC, CD4 count, and HIV RNA count for the last year. Here are the results:

CBC w/ Diff

Normal Range

Jan 12

Apr 20

Jul 8

Dec 12

WBC

(4.5 - 10) x 103 per µL 

6.9

5.6

3.6

3.2

Hemoglobin

12.0 - 15.5 g/dL female

13.5 - 16.5 g/dL male

12.5

10.9

8.2

7.0

Hematocrit

35.0 - 50.0 %

36.7

33.4

24.8

22.1

MCV

80.0 - 100.0 fL

85.2

91.2

98.4

109.5

Platelet

150 - 450 thou/µL

278 

266

222

194

PMN

500 - 1500

1250

1120

980

870

Lymphocytes

20 - 44 %

32

29

30

33

CD4 count

500 - 1500 cells/mm3

870

820

788

768

HIV RNA count

0

8,500

7,200

6,400

5,200


Question:

Which of the following medications is the most likely cause of bone marrow suppression (anemia, neutropenia) in this patient?

Answer:
Case:

RN, a 56-year-old male patient, presents to the ER with progressively worsening shortness of breath when walking more than 20 feet, fatigue, and bilateral pitting edema of his legs for the last few months.

Past Medical History:
DM type 2
Long-standing hypertension

Current Medications:
Metformin 1000 mg PO BID
Pioglitazone 30 mg PO once daily
Hydrochlorothiazide 25 mg PO once daily
Lisinopril 40 mg PO once daily
Amlodipine 10 mg PO once daily

Vitals:  BP: 110/63 mmHg    P: 110,    Resp Rate: 22    Temp: 97.8

Labs:
BUN  ................................   19 mg/dL (6-20)
Serum Creatinine .............    1.1 mg/dL (0.6-1.2)
Potassium .......................     3.1 mEq/L (3.5-5.2)
BNP ................................     960 (10-300)
Troponins .......................     Negative

Imaging Studies:
Chest x-ray:
 Enlarged cardiac silhouette, mild pulmonary edema
Echocardiogram: Ejection Fraction: 30%


Question:

Which of his medications may be worsening his pulmonary edema and leg edema symptoms? Select ALL that apply.

Answer:
Case:

UM, a 58-year-old female presents to the ER complaining of heart palpitations, fatigue, and slight lightheadedness.
On exam, she was found to have an irregular pulse, and her 12-lead ECG showed atrial fibrillation (AF).

Past Medical History: 
HTN,
DM type 2
Obesity

Family History: Father had CAD

Allergy: Shellfish allergy

Medications:
HCTZ 25 mg PO once daily
Fortamet  2500 mg PO once daily
Glyburide 5 mg PO once daily

Physical Exam:
Vitals: BP: 167/91 mmHg    P: 122     RR: 18     T: 98.4     O2Sat: 97%

Labs:
Troponin I  ..................  Negative
Glucose  .....................  230 mg/dL
BUN ............................  30 mg/dL
Creatinine  ..................  1.0 mg/dL

12-lead ECG: Atrial fibrillation with a ventricular rate of 122 bpm


Question:

Based on her CHA2DS2-VAS score, which of the following medications would be the MOST appropriate for her treatment?

Answer:
Case:

MK is a 49-year-old male with history of liver cirrhosis. He is brought to ER by family members with a chief complaint of confusion and altered mental status for the last 24 hours.

On exam, MK is difficult to arouse; he is not oriented to time, person or place.

Vitals:   BP: 110/67 mmHg       P: 80          RR: 14       Temp 98.6

Labs:

Comprehensive Metabolic Panel:

 

Normal Range

Results

Sodium

135 – 145 mEq/L

138

Potassium

3.5 5.2 mEq/L

4.2

Chloride

97 – 108 mEq/L

100

HCO3

23 – 29 mEq/L 

25

Calcium

8.5 – 10.2 mg/dL

9.2

BUN

6 – 20 mg/dL

15

Creatinine

0.6 – 1.3 mg/dL

1.0

Glucose

70 – 100 mg/dL

85

ALT

< 35 U/L            

52

AST

< 35 U/L

55

Albumin

3.4 – 5.4 g/dL

2.0

Bilirubin

0.3 – 1.9 mg/dL

4.0

Ammonia

15 45 mcg/dL

110


INR ………………….   2.1

Urine analysis & Lumbar puncture results are normal.

Question:

Which of the following treatment measures do you recommend? Select ALL that apply.

Answer:
Question:

DB is a 67-year-old male with ESRD on dialysis who has been on Epogen 3000 units SC three times a week for anemia of chronic renal failure. His recent labs are as follows:

Hgb …………………. 12.6 g/dL (13.5 – 16.5 g/dL for males)
Hct …………………… 38.6 % (40% – 52%)
MCV …………………. 86 fL
WBC ………………… 4.0 thous/microL
Platelets …………….. 185 thous/microL

With regards to his Epogen dosing, what would be the most appropriate course of action?

Answer:
Case:

JB a 59-year-old female patient with newly diagnosed pyelonephritis has been unable to hold PO fluids and oral antibiotics due to severe vomiting. As a result, she has been admitted to the hospital for IV fluids and antibiotic therapy. She is otherwise healthy, and her CrCl was calculated to be 85 mL/hour. Her IV fluids and medication orders during the first 3 days of her hospital stay are as follows:

October 17 (Day of admission):
Normal Saline  1/2 liter + 20 mEq KCl for the first 5 hours, then change to IV maintenance with D5 1/2 NS at 100 mL/hour.
Levofloxacin 500 mg IV daily
Heparin 5000 units SC twice daily
Famotidine 20 mg IV twice daily
Zofran 4 mg IV Q 8 hours PRN nausea/vomit

October 18 (Day 2):
D5 1/2 NS at a 100 mL/hour
Levofloxacin 500 mg IV daily
Heparin 5000 units SC twice daily
Famotidine 20 mg IV twice daily
Zofran 4 mg IV Q 8 hours PRN nausea/vomit

October 19 (Day 3):
D/C  IV fluid D5 1/2 NS from 10/18
Lactated Ringers at a 100 mL/hour
Levofloxacin 500 mg IV daily
Heparin 5000 units SC twice daily
Famotidine 20 mg IV twice daily
Zofran 4 mg IV Q 8 hours PRN nausea/vomit

On the first day of admission, the patient received 1/2 liter NS with 20 mEq KCl for the first 5 hours and then changed to IV maintenance with D5 1/2 NS at a rate of 100 mL/hour for the next 10 hours of the day. 


Question:

How many mEq of Na+ has the patient received in total from her IV fluids on 10/17? 


Round off your final answer to ONE decimal point.

Answer:
  mEq
Calculator
Case:
A 54-year-old male presents to the ER with a seizure. His wife was awakened at 5:30 A.M by her husband making an odd gurgling noise with his head deviating to the left, and his left arm tonically stiffened. This was followed by generalized body jerking. In the ER, his wife states that he has returned to baseline.

PMH: Type 2 DM

Vitals and physical exam: essentially normal

Current Medications:
Metformin
Hydrochlorothiazide
Contrave
Suprenza

Labs

Na+

138 mEq/L (135-145)

 

WBC

10.2 thou/µL (3.5-10.5)

K+

4.2 mEq/L (3.5-5.2)

Hemoglobin

14.4 g/dL (12.0-15.5)

BUN

22 mg/dL

Platelets

167 thou/µL (150-450)

Serum Creatinine

1.1 mg/dL

   

Glucose

87 mg/dL

   

ALT

21 U/L

   

Question:
Which of the following medications could have been the culprit for his seizure? Select ALL that apply.
Answer:

Your score:

You correctly answered out of questions.



Retake Quiz

Review Incorrect Answers

Topics Covered in Live Course

This is a list of ALL the topics covered in the coursebook and the Online video lectures.

Please note due to time constraints, some of the topics below (covered in the coursebook and online course) will NOT be lectured on during the Live Review. 

Hypertension

Hypertensive emergency

Congestive Heart Failure

Atrial Fibrillation

Anti-Arrhythmics

Anti-Coagulants

Anti-platelets

Thrombolytics

Stroke

Angina

Acute Coronary Syndrome

Myocardial Infarction

Autonomic Nervous System

Dyslipidemia

Interpreting LABS

Electrolytes

Metabolic panels

Renal and Hepatic dysfunction

CBC and Anemias

Asthma & COPD

Nebulizers and MDIs

Diabetes Mellitus

Chemotherapy

Osteoporosis

Contraceptives

Womens' health

Rheumatoid Arthritis 

GERD / PUD

Pregnancy  

Smoking Cessation

Pain Management

Muscle Relaxants

Insomnia 

Medication Safety

Patient Profiles / Inpatient cases

Calculations

Statistics

Compounding

IV Incompatibilities

TPN

Ulcerative Colitis

Crohn's disease

Irritable Bowel Syndrome

Multiple Sclerosis

Transplant Drugs

Antibiotics

Antivirals

Antifungals

Tuberculosis

HIV  /  AIDS

Immunizations

Anxiety and related disorders

Depression

Bipolar disorder

Schizophrenia

Parkinson's

CNS Stimulants

Weight loss

Alzheimer's

Migraine

Seizure

Gout

Herbals

OTC

Thyroid Meds

Ophthalmic Meds

Cystic Fibrosis

Sickle Cell Disease

Erectile Dysfunction

 

 

Accommodations


This is a LIVE VIRTUAL class. Zoom Registration Information will be emailed to registered students a few days before the live class.

Register Now:

Course Title
Dates
Price
Location
 
NAPLEX & Clinical CPJE, 7-day Live Virtual Course
July 6-12, 2022
$1,350
7 Days Live Virtual Class Room
Live Course + Online Course Bundle
July 6-12, 2022
$1,650
7 Days Live Virtual Class Room